trending Market Intelligence /marketintelligence/en/news-insights/trending/ccx31n5q25rnwj2oayeypg2 content esgSubNav
In This List

Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Merck & Co. to create 350 jobs at new manufacturing facility in Ireland

Merck & Co. Inc. plans to create 350 new jobs by building a biologics manufacturing facility at its Swords site near Dublin, Ireland, FiercePharma reported Feb. 14.

Biologics are large molecules derived from natural sources, such as microorganisms or plant or animal cells.

The company plans to use the new facility to produce its blockbuster cancer drug Keytruda.

Merck expects the plant to be ready by 2021 and start producing commercial products the next year, the news outlet reported.